ProQR Therapeutics N.V.
PRQR
$2.26
$0.052.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.91% | 3.58% | |||
| Total Other Revenue | -23.24% | 61.10% | |||
| Total Revenue | -9.58% | 5.34% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -9.58% | 5.34% | |||
| SG&A Expenses | 60.60% | -18.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.47% | 5.74% | |||
| Operating Income | -22.14% | -5.92% | |||
| Income Before Tax | -30.13% | -6.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.32% | -6.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.32% | -6.93% | |||
| EBIT | -22.14% | -5.92% | |||
| EBITDA | -23.12% | -1.53% | |||
| EPS Basic | -30.29% | -0.90% | |||
| Normalized Basic EPS | -30.00% | -0.96% | |||
| EPS Diluted | -29.47% | -5.41% | |||
| Normalized Diluted EPS | -30.00% | -0.96% | |||
| Average Basic Shares Outstanding | 0.04% | 5.90% | |||
| Average Diluted Shares Outstanding | 0.04% | 5.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||